Every cancer is different.
Understanding it matters.

The 6th most common cancer in men — often caught early.

Includes leukemia, lymphoma and myeloma — cancers affecting the blood and bone marrow.

Includes glioblastoma, the focus of NFCR’s GBM AGILE trial.

The most common cancer among women in the U.S.

Largely preventable through screening and HPV vaccination.

Affects children and teens, from leukemia to brain tumors.

A leading cause of cancer death — screening can help save lives.

Often linked to tobacco, alcohol and HPV.

Among the ten most common cancers in the U.S.

Often linked to hepatitis B and C infections.

The leading cause of cancer death worldwide — driving urgent research into prevention, detection and treatment.

When cancer spreads beyond where it began — a core focus of NFCR research.

Early signs can be subtle — knowing the warning signs can help prompt earlier evaluation.

One of the deadliest major cancers — making earlier detection a critical research priority.

The most common cancer in U.S. men after skin cancer.

Rare cancer of bone and soft tissue, with many distinct subtypes.

The most common cancer in the U.S. — and highly preventable.

Often diagnosed at later stages — knowing the warning signs matters.

The most common cancer in young men — highly curable when found early.

Highly treatable, especially when found early.

The most common gynecologic cancer in the U.S.